Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by ZYUS Life Sciences Corporation

ZYUS Life Sciences Finalizing Site Initiation for Phase 2A Clinical Trial Advancing Novel Non-Opioid Pain Drug
From ZYUS Life Sciences Corporation
Via Business Wire
Tickers TSX-V:ZYUS
INSERTING and REPLACING ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9
From ZYUS Life Sciences Corporation
Via Business Wire
Tickers TSX-V:ZYUS
ZYUS Life Sciences Receives United States Patent No. 11,963,943 Covering Pain Management
From ZYUS Life Sciences Corporation
Via Business Wire
Tickers TSX-V:ZYUS
ZYUS Strengthens Expertise of Clinical Advisory Committee with the Appointment of Dr. Hance Clarke
From ZYUS Life Sciences Corporation
Via Business Wire
Tickers TSX-V:ZYUS
ZYUS Strengthens Leadership Team with Appointment of Vice President of Clinical Research
From ZYUS Life Sciences Corporation
Via Business Wire
Tickers TSX-V:ZYUS
ZYUS Life Sciences Corporation Announces Phase 2 Clinical Trial Evaluating Trichomylin® Softgel Capsules for Advanced Cancer Pain Management
From ZYUS Life Sciences Corporation
Via Business Wire
Tickers TSX-V:ZYUS
ZYUS Life Sciences Corporation Announces Positive Phase I Clinical Trial Results for Trichomylin® Softgels
From ZYUS Life Sciences Corporation
Via Business Wire
Tickers TSX-V:ZYUS
ZYUS Life Sciences Corporation Announces New Director of Investor Relations and Capital Markets
From ZYUS Life Sciences Corporation
Via Business Wire
Tickers TSX-V:ZYUS
ZYUS Life Sciences Corporation Obtains Health Canada Security Clearance for New Board Member Wayne Brownlee
From ZYUS Life Sciences Corporation
Via Business Wire
ZYUS Life Sciences Announces Final Approval to Commence Trading on June 19, 2023, and Engages Independent Trading Group (“ITG”) as Market Maker
From ZYUS Life Sciences Corporation
Via Business Wire
ZYUS Life Sciences Corporation Announces Completion of RTO
From ZYUS Life Sciences Corporation
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.